3.
EGFR突变肺腺癌102例手术标本中主要病理分型的构成及其与外显子的关系
Relationship with the major pathology type and the exon of 102 cases of surgical specimen of lung adenocarcinoma with EGFR mutation[n(%)]
Pathological type* | n | Exon 18 | Exon 19 | Exon 20 | Exon 21 | Exons 20, 21 | Exons 19, 21 | Exons 18, 19 | Exons 18, 20 | Exons 19, 20 |
*: the pathology type was the major in the case. | ||||||||||
Total | 102 | 1(0.98) | 45(44.12) | 3(2.94) | 44(43.14) | 1(0.98) | 3(2.94) | 2(3.57) | 2(3.57) | 1(1.79) |
Lepidic | 24 | 0 | 4(16.67) | 2(8.3) | 17(70.83) | 0 | 1(4.17) | 0 | 0 | 0 |
Acinar | 56 | 1(1.79) | 26(46.43) | 0 | 21(37.5) | 1(1.79) | 2(3.57) | 2(3.57) | 2(3.57) | 1(1.79) |
Papillary | 18 | 0 | 12(66.67) | 1(5.56) | 5(27.78) | 0 | 0 | 0 | 0 | 0 |
Micropapillary | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Solid | 4 | 0 | 3(75.00) | 0 | 1(25.00) | 0 | 0 | 0 | 0 | 0 |